Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks

NCT00168103 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.

NCT NCT00168103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Pasteurized C1 Esterase Inhibitor Concentrate (CE1145) in Subjects With Congenital C1-INH Deficiency and Acute Abdominal or Facial HAE Attacks
Lead sponsor
CSL Behring
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2005
Completion date
December 31, 2007
Enrollment
126 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema